Handa Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2014
Period Ending	Nov '24 Nov 20, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2014
Market Capitalization	8,147	25,891	16,074	8,451	2,820	3,477	Upgrade
Market Cap Growth	-35.17%	61.07%	90.20%	199.72%	-18.91%	3.61%	Upgrade
Enterprise Value	5,656	23,747	15,869	8,249	2,326	2,919	Upgrade
Last Close Price	57.70	182.21	120.73	67.04	23.53	29.02	Upgrade
PE Ratio	17.80	35.62	-	-	-	-	Upgrade
PS Ratio	8.27	23.40	81.32	289.08	97.71	41.36	Upgrade
PB Ratio	2.81	9.39	22.29	18.25	5.23	4.23	Upgrade
P/TBV Ratio	5.17	9.52	23.46	19.80	5.59	4.45	Upgrade
P/FCF Ratio	10.94	38.79	-	-	-	-	Upgrade
P/OCF Ratio	19.84	38.74	-	-	-	-	Upgrade
EV/Sales Ratio	5.81	21.46	80.28	282.15	80.61	34.72	Upgrade
EV/EBITDA Ratio	10.46	34.00	-	-	-	-	Upgrade
EV/EBIT Ratio	10.65	34.25	-	-	-	-	Upgrade
EV/FCF Ratio	7.59	35.58	-	-	-	-	Upgrade
Debt / Equity Ratio	0.01	0.00	0.04	0.03	0.02	0.02	Upgrade
Debt / EBITDA Ratio	0.07	0.02	-	-	-	-	Upgrade
Debt / FCF Ratio	0.05	0.02	-	-	-	-	Upgrade
Asset Turnover	0.43	0.58	0.31	0.05	0.04	0.10	Upgrade
Quick Ratio	17.71	12.93	11.63	10.05	9.05	15.60	Upgrade
Current Ratio	17.75	12.96	13.07	10.57	10.79	16.71	Upgrade
Return on Equity (ROE)	21.92%	41.81%	-6.76%	-49.43%	-41.47%	-23.73%	Upgrade
Return on Assets (ROA)	14.66%	22.64%	-8.54%	-29.36%	-27.20%	-15.98%	Upgrade
Return on Capital (ROIC)	15.71%	24.62%	-8.99%	-30.89%	-28.46%	-16.84%	Upgrade
Earnings Yield	5.62%	2.81%	-0.25%	-2.93%	-10.00%	-5.11%	Upgrade
FCF Yield	9.14%	2.58%	-1.32%	-2.19%	-11.20%	-6.78%	Upgrade
Dividend Yield	1.71%	0.55%	-	-	-	-	Upgrade
Buyback Yield / Dilution	-7.81%	-7.29%	-6.65%	-1.87%	-5.35%	-4.89%	Upgrade
Total Shareholder Return	-6.10%	-6.74%	-6.65%	-1.87%	-5.35%	-4.89%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.